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Differential Impact of Bleeding Avoidance Strategies on Risk-Adjusted PCI-Related 
Bleeding Rates Within a Large Multistate Health System
Ty J. Gluckman, MD1, Lian Wang, MS1, Kateri J. Spinelli, PhD1, John L. Petersen II, MD2, Paul Huang, MD2, Sunil V. Rao, MD3
Background
• Percutaneous coronary intervention (PCI)-related bleeding is associated with increased 
morbidity, mortality, and cost1
• Trans-radial access (RAD), bivalirudin (BIV), and vascular closure devices (VCD) represent 
strategies to reduce PCI-related bleeding 
• The relative impact of these bleeding avoidance strategies (BAS) across bleeding risk strata has 
not been previously reported
Results
• Raw PCI-related bleeding rates were 4.4% overall and 9.6%, 5.8%, 5.4%, 3.2%, 2.0%, and 
1.7% in patients receiving no BAS, BIV, VCD, VCD + BIV, RAD, and RAD + BIV, respectively 
(Figure 1)
• Non-access site bleeds accounted for 93% of PCI-related bleeding events overall
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Methods
• Retrospective cohort analysis of 74,953 PCIs within a multistate healthcare system from 
2009Q3-2017Q4
• Exclusion criteria included non-index PCI, patients who died the same day or were missing data 
related to bleeding, patients who underwent CABG surgery during the same episode of care, 
and patients with undetermined BAS due to missing data
• Bleeding risk was assessed per the NCDR CathPCI bleeding model2; procedures were stratified 
into six bleeding risk groups to achieve balanced risk between BAS in each group: 1st quartile, 
2nd quartile, 3rd quartile, 75th-90th percentile, 90th-97.5th percentile, and top 2.5th percentile
• Within each risk stratum, multivariable regression modeling was used to assess the impact of 
BAS on bleeding with the logit of predicted risk as a factor and Bonferroni adjustment to control 
for multiple comparisons
Conclusions
• Further efforts should be directed at maximizing use of bleeding avoidance strategies, 
particularly among those at higher bleeding risk
• If only a single intervention is used, trans-radial access represents the preferred bleeding 
avoidance strategy to minimize PCI-related bleeding
• While the addition of bivalirudin to a vascular closure device is associated with significantly 
reduced bleeding, bivalirudin does not convey this same benefit when added to trans-radial PCI
1. Center for Cardiovascular Analytics, Research and Data Science (CARDS), Providence Heart Institute, Providence St. Joseph Health, Portland, OR. 2. Swedish Heart and Vascular Institute, Providence St. 
Joseph Health, Seattle, WA. 3. Duke Clinical Research Institute, Durham, NC.
Figure 1 – Raw bleeding rates. Absolute rates of PCI-related bleeding (numbers above the 
bars) and absolute rates of access site bleeding (numbers in white within the bars) for listed 
BAS. Group sample sizes are in parentheses after the group labels. BAS = bleeding 
avoidance strategies, BIV = bivalirudin, VCD = vascular closure device, RAD = trans-radial 
access 
Variable Overall No BAS BIV VCD BIV+VCD RAD RAD+BIV











Age, yrs 66 (58, 74) 67 (58, 76) 67 (59, 75) 66 (58, 75) 65 (57, 74) 65 (57, 73) 65 (57, 72)
Female 27.6 31.2 30.1 26.3 27.9 25.9 27.9
BMI, kg/m2 28.9 28.7 28.8 28.7 28.7 29.4 29.8
DM 34.5 36 34.4 35.7 33.4 33.4 35.5
PVD 11 17.2 13.7 10.9 9 9.7 9.6
Prior PCI 38.2 38.7 41.8 38.5 38.9 35.1 37.5
Prior CABG 15.8 21.4 21.4 19.3 17.1 6.1 8
Prior MI 31 32.9 32.5 33.1 30.1 28.2 28.4
Renal failure 2.5 4.2 2.6 3.5 2.3 1.2 0.6
Pre-PCI Hb, g/dl 13.9 13.7 13.8 13.9 13.8 14 13.9
Elective 36.6 30.1 41 33.9 38.2 36.7 42.8
Urgent 40.4 36.6 34.7 39.9 40.6 45.1 43.9
Emergent 22.5 31.7 23.2 25.8 20.8 18 13
ACS 78.8 85 80.1 79.8 76.6 76.9 77.2
STEMI 20.5 28.3 19.8 24.1 19.2 16.3 12.6
Shock 3.2 8.7 4.5 3.5 2.1 1.5 1.1
MCS 2.3 7.1 3.9 2.5 1.0 1.0 0.7
GP 2b/3a inhibitor 15.5 32.7 6.9 24.9 7.5 12.1 9
CathPCI mortality risk 
score, %






















• Using real-world data from a large multistate health system, we sought to evaluate the impact of 
BAS either individually or in combination among patients undergoing PCI with varying levels of 
bleeding risk
Figure 2 – Predicted risk stratification. (A) Predicted bleeding risk groups, stratified by the 
NCDR CathPCI bleeding risk model (B) use of BAS across strata of predicted bleeding risk (C) 
raw rates of bleeding for BAS across strata of predicting bleeding risk. Abbreviations defined in 
Figure 1. 
• For those treated with a single BAS, only RAD use was associated with a significantly lower risk 
of PCI-related bleeding across all risk strata, compared to no BAS (Figure 3)
• Compared to no BAS, VCD + BIV use was associated with a significantly lower risk of PCI-
related bleeding; this benefit was not observed when a VCD or BIV was used alone
• RAD use was associated with a significantly lower risk of PCI-related bleeding compared to BIV 
across all bleeding risk groups except for those at the top 2.5th percentile
• Addition of BIV to RAD did not lower the risk of PCI-related bleeding across any of the bleeding 
risk groups, compared to RAD alone
• The six risk groups had predicted bleeding rates of <2.7%, 2.7-4.1%, 4.2-8.6%, 8.7-14.9%, 15.0-
33.9% and ≥34.0% (Figure 2) 
• A risk-treatment paradox was observed, with greatest underuse of BAS among those at greatest 
bleeding risk 
• In addition, use of RAD, VCD + BIV and RAD + BIV progressively decreased as bleeding risk 
increased
Figure 3 – Risk-adjusted bleeding rates . Multivariate analysis of bleeding outcomes 
(adjusted for GP 2b/3a inhibitor use) comparing BIV to no BAS (A), VCD to no BAS (B), 
VCD + BIV to no BAS (C), RAD to no BAS (D), RAD to BIV (E) and RAD + BIV to RAD 
(F). The marker size is representative of the sample size for each risk group. Odds ratios 
and 95% confidence intervals are displayed. Abbreviations defined in Figure 1. 
Table 1: Demographics
Values are median (interquartile range) or %
BMI = body mass index, PCI = percutaneous coronary intervention, CABG = coronary artery bypass graft, MI = myocardial infarction, Hb = hemoglobin, 
ACS = acute coronary syndrome, STEMI = ST-segment elevation myocardial infarction, MCS = mechanical circulatory support
